Greenidge Generation received a Nasdaq notice for non-compliance with audit committee independence rules following a director resignation, with a cure period until April 2027.
Key takeaways
Nasdaq confirmed non-compliance with Listing Rule 5605(c)(2)(A) after Kenneth Fearn resigned from the audit committee.
Company has a cure period until the earlier of next annual meeting or April 15, 2027, to regain compliance.
If next annual meeting is before October 12, 2026, compliance must be achieved by October 12, 2026.
Board is actively recruiting a new independent director to fill the audit committee vacancy.
Notice has no immediate effect on listing or trading of Class A common stock.